Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 20, Issue 5, May 1995

MONOGRAPHS

Abciximab. Platelet glycoprotein gpll/llla inhibitor. C. Robinson

Docetaxel. Antineoplastic, Microtubule stabilizer. J.L. Fabre, D. Loci-Tonelli, C.H. Spiridonidis

KSG-504. Cholecystokinin-A receptor antagonist. Y. Yamazaki et al.

Napsagatran. Thrombin inhibitor. T.B. Tschopp et al.

Ranitidine Bismuth Citrate. Antiulcerative, Gastric antisecretory agent. X. Rabasseda, N. Mealy, J. Castañer

Topotecan Hydrochloride. Antineoplastic, Topoisomerase I inhibitor. C.H. Spiridonidis, J. Castañer

Ularitide. Treatment for postoperative acute renal failure. M. Meyer et al.

REVIEW ARTICLES

Chemosensitizers in tumor therapy: new compounds promise better efficacy: R. Boer and V. Gekeler

Hypericin in adjuvant brain tumor therapy: L. Anker, R. Gopalakrishna, K.D. Jones, R.E. Law, W.T. Couldwell

Information Update 1-19
A-007
Abecarnil
Alaptide
Amperozide
Aranoza
ARI-509
AS-101
Atipamezole
Atrimustine
B-GYKI-38233
Balsalazide
Besigomsin
Bidisomide
Brofaromine Hydrochloride
CAM
Deferiprone
DN-2327
Dopropidil Hydrochloride
Droxidopa
Emedastine Fumarate
Emitefur
Epiroprim
Fluticasone Propionate
Gossypol
GYKI-46903
ICI-D0870
ICI-D8731
Ipsapirone Hydrochloride
Itazigrel
KP-736
Manoalide
MCI-225
Mitoxantrone Hydrochloride
Mofegiline Hydrochloride
N-0861
NC-1200
Ono-3708
Org-2766
Panomifene
Posatirelin
Q-35
Repagermanium
Ridogrel
Ritanserin
RU-47213
Saterinone
Sparfloxacin
Toremifene
Trimetrexate
Trimetrexate Glucuronate
Turosteride
Umespirone
Vorozole
Vratizolin


 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy